Concepedia
Statistics
Publications
17
Citations
537
H-Index
13
Active since
1991
Affiliations
UCB Pharma (United Kingdom)(Current)
Eindhoven University of Technology
Johnson & Johnson (United States)
University of Southampton
International Tin Research Institute
Jeremy Davis is an author at UCB Pharma (United Kingdom) specializing in medicinal chemistry, pharmacology, and organic chemistry.
Publications per year
1991–2021
Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors
John Porter, Andrew Payne, Ben de Candole et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 123 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +9
c-Jun N-Terminal Kinase Primes Endothelial Cells at Atheroprone Sites for Apoptosis
Hera Chaudhury, Mustafa Zakkar, Joseph Boyle et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2010 · 65 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +17
Formation of zirconocene η2-imine complexes by rearrangement of cyclic iminoacyl complexes.
Jeremy Davis, Richard J. Whitby, Albert Jaxa‐Chamiec · Tetrahedron Letters · 1992 · 62 citations
Natural Sciences, Chemistry, Medicinal Chemistry +14
4-Aryl-5-cyano-2-aminopyrimidines as VEGF-R2 inhibitors: Synthesis and biological evaluation
Terry V. Hughes, Stuart L. Emanuel, Amanda K. Beck et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 45 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +14
1-Azadiene complexes of zirconocene
Jeremy Davis, Richard J. Whitby, Albert Jaxa‐Chamiec · Journal of the Chemical Society Chemical Communications · 1991 · 33 citations
Natural Sciences, Chemistry, Inorganic Chemistry +12
1–5 of 17